IT is a commonplace of clinical practice that patients with thyroid disease often have relatives who have also had thyroid disease. This is true not only for patients with Graves' disease, but for those with nodular goitre, and frequently and inexplicably a patient with one of these conditions will describe the other among his relatives. An example of this appears in Fig. 1 , which is the family tree of a young woman with the classic findings of Graves' disease who numbered among her immediate kindred at least seven persons with thyroid disease. One of these had been operated on for Graves' disease, and four others had required surgery for nontoxic enlargement of the gland. Familial relationships of this kind indicate a common genetic endowment, which is the constitutional factor in the disease.
The biochemical genetics which rationalizes the constitutional factors of Graves' disease and of nodular goitre has not yet been realized. There are, on the other hand, certain rare types of thyroid disease which clearly have a genetic origin and which have become of special interest FIG. 1.-The genetic chart of a young woman with classical Graves' disease. Note that in the family there are patients with Graves' disease, as well as those with nontoxic goitre. because some insight has been gained into the genetically determined biochemical abnormalities which lie at the root of each. Five and perhaps six distinct groups of these patients are now delineated. These patients are usually goitrous and hypothyroid, but some of their relatives, who are goitrous but otherwise normal, are now recognized as being heterozygous for the genetic lesion for which the patients are homozygous. Further, it is clear that in at least two types the clinical appearance of the disorder depends on the amount of iodide in the diet; the disturbance would never have come to clinical recognition except for the restriction of iodide supply.
Iodide Trapping Defect
A genetically-conditioned defect in the earliest step in thyroid hormone synthesis is the most recently described type of hypothyroidism with goitre (Stanbury and Chapman, 1960) . This disease has been described so far in a single patient, a 15-year-old boy with moderate enlargement of his thyroid gland and clinical hypothyroidism. There were at least three consanguine marriages in his immediate forbears, and several members of his family, including his father, are known to be goitrous. The clinical impression of hypothyroidism was confirmed when the proteinbound iodine concentration of the serum proved to be 0 5 ,g/100 ml, and his basal metabolic rate, -38%.
When it was found that there was scarcely any accumulation of radioactive iodide in his thyroid, it was suspected that there might be defective trapping of iodide by the epithelial cells of the gland. Two types of evidence confirmed this hypothesis. It was found that the salivary glands and the gastric mucosa, which, like the thyroid, are derived from the primitive gut and which normally also concentrate iodide, were also unable to concentrate iodide. Unlike the normal these structures were also unable to concentrate thiocyanate, a substance which competes for 'From the Department of Medicine, Harvard Medical School and Massachusetts General Hospital (Thyroid Unit), Boston, Mass. The studies reported herein have been supported variously by the U.S. Public Health Service, the American Cancer Society, and the U.S. Atomic Energy Commission. iodide trapping sites in the normal thyroid gland. Furthermore, thyroid tissue slices obtained at biopsy were unable to concentrate iodide, and an analysis of these slices disclosed only minute amounts of iodide or of organically-bound iodine.
It seemed reasonable to suppose that, if the only defect in the thyroid gland of this patient was an inability to trap iodide, raising the serum concentration of iodide sufficiently high, would lead to enough iodide entering the gland by simple diffusion to compensate for the missing concentrating mechanism. Accordingly, the patient was given a milligram of potassium iodide three times daily at the time of discharge from the hospital. Within six weeks the basal metabolic rate was +8%, clinical evidence of hypothyroidism had disappeared and the goitre was barely palpable.
The defect encountered in this patient is illustrated in Fig. 2 . Inorganic iodide in the The Iodide Organification Defect This group first came to attention in 1949 when a family was studied in which 4 out of 7 siblings were severely cretinous and had huge hyperplastic goitres (Stanbury and Hedge, 1950) . When these patients were given a small amount of radioactive iodide it accumulated with unusual rapidity in the thyroid. After several hours a gram of potassium thiocyanate was given orally and there was an immediate and precipitous discharge of the radioactive iodide from the gland. Thiocyanate displaces inorganic iodide, but not organically bound iodine from the thyroid. This finding was interpreted to mean that the glands of these patients were unable to convert iodide into organic combination with tyrosyl residues of the thyroglobulin (Fig. 3 ). This formulation was confirmed when in later studies it was found that the rate at which iodide disappeared from the thyroid of these patients was governed by the rate of renal clearance of inorganic iodine and further, that the BLOCK I-1% N I.. I.. '11,--KJ -d n 8 y FIG. 2.-A diagram to illustrate the iodide-trapping defect. Serum iodide enters the thyroid only by diffusion. Because the selective concentrating mechanism for iodide is missing the serum iodide is rapidly cleared from the body by the kidney. plasma perfusing the gland enters the follicles only by passive diffusion because the normal concentrating mechanism is not functioning. Almost all of the available iodide is lost from the body by renal excretion. It is evident that this defect would not have come to attention if this patient had lived in an environment which provided him with a milligram or more of iodide daily.
The father of the patient also had a goitre but the uptake of radioiodide by his thyroid and the capacity of his salivary glands to concentrate iodide were unimpaired even after administration of a large amount of stable iodide. Thus it was not possible to demonstrate limitation of iodide trapping as heterozygous expression of the defect. organification defect. An ample quantity of iodide is concentrated in the thyroid gland but because the specific iodide peroxidase, the enzyme presumed to be necessary for the conversion of iodide to iodine, is missing, the trapped iodide can be discharged from the thyroid by thiocyanate and is excreted by the kidney. No organic compounds of iodine are produced by the gland. amount of organic iodine in surgical specimens of thyroid tissue from these patients was negligible. It was of. genetic interest that the parents of the initial family in this group were first cousins and that there were several consanguine marriages among their forbears. Recently Haddad and Sidbury (1959) have found that tissue slices from the thyroid of a similar patient failed to form any organic iodine, and concluded that the normal iodide peroxidase is probably missing.
A number of cases of what is clearly the same malady have now been described. In addition, 51 905
Proceedings of the Roj certain patients with goitre and deafness and with or without hypothyroidism have been grouped under the eponym, "Pendred's syndrome" (Trotter, 1960) . This disease is apparently inherited as a dominant character with incomplete penetrance, in contrast to the other diseases which are described here and which have an autosomal recessive pattern of inheritance. These patients are also thought to have a defect in organic binding of iodide because a fraction of the accumulated radioiodine is dischargeable with thiocyanate under the conditions which have been employed in the study of these patients.
The discharge of iodide with thiocyanate or perchlorate has generally been done within two hours or less of administration of the isotope, and the degree of discharge has been only moderate in most cases. There is at present no satisfactory answer to the question of whether such modest discharge of iodide so early after administration may simply be an inevitable and nonspecific result of glandular hyperplasia, with iodide organification being a rate limiting step. Indeed, recent studies by Dimitriadou et al. (1960) indicate that in nodular thyroids there is often an increase in the amount of iodide and monoiodotyrosine relative to the total amount of iodine in the gland. It cannot be said on present evidence that Pendred's syndrome is a result of a specific block in the organification of iodide. One must also interpret with caution the recent finding of Floyd et al. (1960) , who found that many patients with familial nodular goitre have thiocyanate dischargeable iodide in their thyroid glands. To be certain of the iodide organification defect one should show that there is dischargeable iodide even several hours after administration of 131J, and that there is impaired synthesis of iodinated amino acids.
Iodotyrosyl Coupling Defect
Two sisters with large goitres, hypothyroidism, and retarded mental and physical development first drew our attention to defective coupling of iodotyrosyl residues into hormonally active iodothyronines (Stanbury et al., 1955) . These patients were the outcome of at least three consanguine marriages. The uptake of radioiodide by the thyroid glands was extremely rapid and reached nearly 100%. When propylthiouracil was given to block re-utilization of iodide, a huge amount of iodine left the gland, but this was not hormonal iodine, since the patients were not hyperthyroid. This iodide appeared to be derived from a blocking by the drug of a much increased intrathyroidal recycling of iodide through iodotyrosyl residues. The abnormality pal Society of Medicine 52 is shown diagrammatically in Fig. 4 . Direct analysis of one of the glands removed surgically disclosed large amounts of iodotyrosyl residues and scarcely any iodothyronines. Thus, a block in the coupling of iodotyrosine into iodothyronine is a cause of impaired thyroid hormone synthesis. Hypothyroidism and hyperplastic goitre are the inevitable results. 
The lodotyrosine Dehalogenase Defect
Certain patients are hypothyroid and have hyperplastic goitres because they are unable to deiodinate mono-and di-iodotyrosine. This syndrome first came to attention during the study of a young man with life-long goitre and hypothyroidism who secreted mono-and di-iodotyrosine into his blood and urine (Stanbury et al., 1956; Choufoer et al., 1960) . It was found that in contrast to normal subjects he could remove iodide from neither mononor di-iodotyrosine after intravenous administration of these amino acids. When tissue slices from his gland were incubated with di-iodotyrosine, no deiodination occurred, whereas normally thyroid tissue slices readily deiodinate these substances.
Similar patients have been studied in several laboratories, most notably in that of McGirr (1960) in Glasgow. The nature of the defect appears in Fig. 5 . The normal recycling of iodide through the iodotyrosyl residues does not occur because of the absence of the dehalogenating enzyme. There is a spilling of mono-and di-iodotyrosine into the perfusing blood. Since the enzymatic defect is in other organs as well as the thyroid, mono-and di-iodotyrosine are not deiodinated in the peripheral tissues, and escape THrROG OBUL IN ---P-= ABERRANT PArHwAY   FIG. 5. -In the deiodinase defect the normal internal cycling of iodide from the iodotyrosyl residues to intrathyroidal iodide fails to take place because the iodotyrosyl residues are not deiodinated. These are lost from the gland (dashed line) and excreted by the kidney. This constitutes an uncompensated decrease in net hormone synthesis, and a vicious cycle is instituted.
into the urine (Fig. 5) . The iodide is not recouped for re-utilization. This results in a diversion of iodide into the synthesis of hormonally inactive organic substances which are lost from the body. One might surmise that with enough iodide in the diet the defect would be less apparent, or not apparent at all. This experiment has actually been done by Choufoer (1960) . When large amounts of iodide were given to one of these patients, the signs of hypothyroidism diminished, and the goitre disappeared.
The Syndrome of Butanol-insoluble Serum Iodine
When normal serum is acidified to pH2 and extracted with N-butanol, nearly all of the iodine is found in the butanol fraction. A group of patients with hypothyroidism and goitre is now recognized whose serum is not completely extractable by butanol (DeGroot and Stanbury, 1959) (Fig. 6 ). In these patients usually 60-70% of the serum iodine is butanol extractable, but there remains a fraction which is not extractable but which can be hydrolysed by the usual proteolytic ferments to yield mono-and di-iodotyrosine and thyroxine. It appears that these patients are secreting into the blood an iodinated polypeptide which contains the usual iodinated amino acids of the thyroid gland. The nature of the abnormal component of the blood of these patients has been partly ascertained. It has the electrophoretic mobility of albumin, a low sedimentation constant and at least some of it finds its way into the urine where it may be hydrolysed to some of its component amino acids. We do not know why it is formed and why it is released into the peripheral blood. It could arise from aberrant synthesis of thyroglobulin or from aberrant degradation of thyroglobulin in the process ofhormone mobilization. Recently a patient has been described who has this component as the exclusive inatediod substance in the peripheral blood (Chavarria et al., 1960) . It has been detected also in the blood of a few patients with nodular goitre of long standing without hypothyroidism, and a similar component has been found in the blood of certain patients with cancer of the thyroid (Robbins et al., 1955) .
Discussion
It appears that within the syndrome of familial hypothyroidism and goitre, first described over sixty years ago by Osler (1897), there are at least five biochemically distinct diseases. The clinical similarity of the patients derives from the fact that each biochemically distinct abnormality retards or inhibits at a different stage the process of thyroid hormone formation. The result is compensatory hyperplasia of the gland and clinical evidence of inadequate thyroid hormone supply. In some of these conditions the inhibition of hormone synthesis is complete, in others it is only partial. In at least two of these diseases the enzymatic defect has been demonstrated in tissues other than the thyroid gland. In these cases the disease emerges as one of the thyroid only because of the dominant importance of the particular enzyme in the processes of hormone formation.
At least two of these diseases illustrate the interaction of the genetic endowment with the environment in the production of disease. Both in the dehalogenase defect and in the iodide trapping defect a sufficient ingestion of iodide causes the manifestations of the disease to vanish. In order for the disease to appear not only is the specific constitution necessary but the environment must be appropriate as well. One suspects that iodide deficiency, so long recognized as the cause of endemic goitre, might in certain instances be the result of a mild environmental deficiency of iodide playing upon a constitutional defect common to the people of a particular area.
There is accumulating evidence that definable constitutional defects may play a role in the origin of simple and nodular goitre. Thus many of the relatives of typical cases of the five types of familial goitre described here also have goitre without evidence of hypothyroidism, and in at least one type, the dehalogenase defect, the goitrous relatives were actually found to share partially in the dehalogenase defect and were presumably heterozygotes. With refinement in techniques for measuring specific enzymatic activity in vivo, as by load tests, it will be possible in the future to recognize many types of nodular goitre and to apply specific biochemical tests in diagnosis.
Summary.-(l) Five and perhaps six biochemically distinct types of hypothyroidism with goitre are now recognized. Many of these patients have relatives who have what would customarily be called simple or nodular goitre.
(2) The manifestations of disease in at least two of these types are abolished by administration of large doses of iodide. In this way is illustrated the interaction between constitution and environment in the production of thyroid disease.
